TIAN RUIXIANG Unveils unprecedented Asia-Pacific AI Healthcare Revolution: Strategic Partnership & Acquisition of Singapore’s Top 3 Medical Leaders to Dominate AI-Driven Diagnostics Across Southeast Asia

Beijing/Singapore, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tian Ruixiang Holdings Limited ("Tianruixiang" or the "Company") (NASDAQ: TIRX), a global trailblazer in AI-powered insurance innovation, today announced a landmark expansion of its transformative ecosystem, cementing its position as the undisputed leader in AI-driven healthcare across Southeast Asia and the Asia-Pacific. Building on its historic AI initiative with top-tier global insurance firms, TIRX has entered into strategic partnership and acquisition discussions with Singapore’s top three medical technology leaders, a move set to redefine the future of insurance-clinic integration and precision diagnostics in the region.